Polymicrobial synergy and dysbiosis in inflammatory disease

Trends in Molecular Medicine

Volumn 21, Issue 3, 2015, Pages 172-183

  Lamont, Richard J ^a   Hajishengallis, George ^b  

^a UNIVERSITY OF LOUISVILLE SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PENNSYLVANIA SCHOOL OF DENTAL MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT;

BACTERIUM COLONY; DYSBIOSIS; EPITHELIUM CELL; HOST PATHOGEN INTERACTION; IMMUNE RESPONSE; INFLAMMATORY DISEASE; MACROPHAGE; MICROBIAL COMMUNITY; NEUTROPHIL; NONHUMAN; PERIODONTITIS; REVIEW; BACTERIUM; HUMAN; IMMUNITY; IMMUNOLOGY; INFLAMMATION; METABOLISM; MICROBIOLOGY; ORGANISMAL INTERACTION; PATHOLOGY;

BACTERIA; DYSBIOSIS; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNITY; INFLAMMATION; MICROBIAL INTERACTIONS;

EID: 84924630982     PISSN: 14714914     EISSN: 1471499X     Source Type: Journal    
DOI: 10.1016/j.molmed.2014.11.004     Document Type: Review

References (90)

1. Hajishengallis G., Lamont R.J. Beyond the red complex and into more complexity: the Polymicrobial Synergy and Dysbiosis (PSD) model of periodontal disease etiology. Mol. Oral Microbiol. 2012, 27:409-419.
2. Lee Y.K., Mazmanian S.K. Has the microbiota played a critical role in the evolution of the adaptive immune system?. Science 2010, 330:1768-1773.
3. Hajishengallis G., et al. Low-abundance biofilm species orchestrates inflammatory periodontal disease through the commensal microbiota and complement. Cell Host Microbe 2011, 10:497-506.
4. Whitmore S.E., Lamont R.J. The pathogenic persona of community-associated oral streptococci. Mol. Microbiol. 2011, 81:305-314.
5. Hajishengallis G. The inflammophilic character of the periodontitis-associated microbiota. Mol. Oral Microbiol. 2014, 29:248-257.
6. Hajishengallis G. Immunomicrobial pathogenesis of periodontitis: keystones, pathobionts, and host response. Trends Immunol. 2014, 35:3-11.
7. Wright C.J., et al. Disruption of heterotypic community development by Porphyromonas gingivalis with small molecule inhibitors. Mol. Oral Microbiol. 2014, 29:185-193.
8. Jenkinson H.F., Lamont R.J. Oral microbial communities in sickness and in health. Trends Microbiol. 2005, 13:589-595.
9. Darveau R.P. Periodontitis: a polymicrobial disruption of host homeostasis. Nat. Rev. Microbiol. 2010, 8:481-490.
10. Schenkein H.A. Host responses in maintaining periodontal health and determining periodontal disease. Periodontol. 2000 2006, 40:77-93.
11. Hajishengallis G., Lamont R.J. Breaking bad: manipulation of the host response by Porphyromonas gingivalis. Eur. J. Immunol. 2014, 44:328-338.
12. Darveau R.P., et al. Porphyromonas gingivalis as a potential community activist for disease. J. Dent. Res. 2012, 91:816-820.
13. Jiao Y., et al. Induction of bone loss by pathobiont-mediated nod1 signaling in the oral cavity. Cell Host Microbe 2013, 13:595-601.
14. Dewhirst F.E., et al. The human oral microbiome. J. Bacteriol. 2010, 192:5002-5017.
15. Abusleme L., et al. The subgingival microbiome in health and periodontitis and its relationship with community biomass and inflammation. ISME J. 2013, 7:1016-1025.
16. Griffen A.L., et al. Distinct and complex bacterial profiles in human periodontitis and health revealed by 16S pyrosequencing. ISME J. 2012, 6:1176-1185.
17. Kumar P.S., et al. Changes in periodontal health status are associated with bacterial community shifts as assessed by quantitative 16S cloning and sequencing. J. Clin. Microbiol. 2006, 44:3665-3673.
18. Duran-Pinedo A.E., et al. Community-wide transcriptome of the oral microbiome in subjects with and without periodontitis. ISME J. 2014, 8:1659-1672.
19. Tjalsma H., et al. A bacterial driver-passenger model for colorectal cancer: beyond the usual suspects. Nat. Rev. Microbiol. 2012, 10:575-582.
20. Kesavalu L., et al. Rat model of polymicrobial infection, immunity, and alveolar bone resorption in periodontal disease. Infect. Immun. 2007, 75:1704-1712.
21. Kuboniwa M., et al. Insights into the virulence of oral biofilms: discoveries from proteomics. Expert Rev. Proteomics 2012, 9:311-323.
22. Frias-Lopez J., Duran-Pinedo A. Effect of periodontal pathogens on the metatranscriptome of a healthy multispecies biofilm model. J. Bacteriol. 2012, 194:2082-2095.
23. Byrne D.P., et al. Evidence of mutualism between two periodontal pathogens: co-operative haem acquisition by the HmuY haemophore of Porphyromonas gingivalis and the cysteine protease interpain A (InpA) of Prevotella intermedia. Mol. Oral Microbiol. 2013, 28:219-229.
24. Tan K.H., et al. Porphyromonas gingivalis and Treponema denticola exhibit metabolic symbioses. PLoS Pathog. 2014, 10:e1003955.
25. Meuric V., et al. Treponema denticola improves adhesive capacities of Porphyromonas gingivalis. Mol. Oral Microbiol. 2013, 28:40-53.
26. Wright C.J., et al. Microbial interactions in building of communities. Mol. Oral Microbiol. 2013, 28:83-101.
27. Wright C.J., et al. Characterization of a bacterial tyrosine kinase in Porphyromonas gingivalis involved in polymicrobial synergy. Microbiologyopen 2014, 3:383-394.
28. Maeda K., et al. A Porphyromonas gingivalis tyrosine phosphatase is a multifunctional regulator of virulence attributes. Mol. Microbiol. 2008, 69:1153-1164.
29. Chawla A., et al. Community signalling between Streptococcus gordonii and Porphyromonas gingivalis is controlled by the transcriptional regulator CdhR. Mol. Microbiol. 2010, 78:1510-1522.
30. Daep C.A., et al. Structural dissection and in vivo effectiveness of a peptide inhibitor of Porphyromonas gingivalis adherence to Streptococcus gordonii. Infect. Immun. 2011, 79:67-74.
31. Ramsey M.M., et al. Metabolite cross-feeding enhances virulence in a model polymicrobial infection. PLoS Pathog. 2011, 7:e1002012.
32. Stacy A., et al. Bacterial fight-and-flight responses enhance virulence in a polymicrobial infection. Proc. Natl. Acad. Sci. U.S.A. 2014, 111:7819-7824.
33. Kachlany S.C. Aggregatibacter actinomycetemcomitans leukotoxin: from threat to therapy. J. Dent. Res. 2010, 89:561-570.
34. Wang B.Y., et al. Negative correlation of distributions of Streptococcus cristatus and Porphyromonas gingivalis in subgingival plaque. J. Clin. Microbiol. 2009, 47:3902-3906.
35. Xie H., et al. Streptococcus cristatus ArcA interferes with Porphyromonas gingivalis pathogenicity in mice. J. Periodontal Res. 2012, 47:578-583.
36. Morris J.J., et al. The Black Queen Hypothesis: evolution of dependencies through adaptive gene loss. MBio 2012, 3:e00036-12.
37. Handfield M., et al. Distinct transcriptional profiles characterize oral epithelium-microbiota interactions. Cell Microbiol. 2005, 7:811-823.
38. Saito A., et al. Porphyromonas gingivalis entry into gingival epithelial cells modulated by Fusobacterium nucleatum is dependent on lipid rafts. Microb. Pathog. 2012, 53:234-242.
39. Aruni W., et al. Filifactor alocis: the newly discovered kid on the block with special talents. J. Dent. Res. 2014, 93:725-732.
40. Handfield M., et al. Beyond good and evil in the oral cavity: insights into host-microbe relationships derived from transcriptional profiling of gingival cells. J. Dent. Res. 2008, 87:203-223.
41. Darveau R.P., et al. Local chemokine paralysis, a novel pathogenic mechanism for Porphyromonas gingivalis. Infect. Immun. 1998, 66:1660-1665.
42. Takeuchi H., et al. The serine phosphatase SerB of Porphyromonas gingivalis suppresses IL-8 production by dephosphorylation of NF-κB RelA/p65. PLoS Pathog. 2013, 9:e1003326.
43. Darveau R.P., et al. Ability of bacteria associated with chronic inflammatory disease to stimulate E-selectin expression and promote neutrophil adhesion. Infect. Immun. 1995, 63:1311-1317.
44. Bainbridge B., et al. Role of Porphyromonas gingivalis phosphoserine phosphatase enzyme SerB in inflammation, immune response, and induction of alveolar bone resorption in rats. Infect. Immun. 2010, 78:4560-4569.
45. Jauregui C.E., et al. Suppression of T-cell chemokines by Porphyromonas gingivalis. Infect. Immun. 2013, 81:2288-2295.
46. Gemmell E., et al. The role of T cells in periodontal disease: homeostasis and autoimmunity. Periodontol. 2000 2007, 43:14-40.
47. Moutsopoulos N.M., et al. Porphyromonas gingivalis promotes Th17 inducing pathways in chronic periodontitis. J. Autoimmun. 2012, 39:294-303.
48. Shin J.E., et al. A periodontal pathogen Treponema denticola hijacks the Fusobacterium nucleatum-driven host response. Immunol. Cell Biol. 2013, 91:503-510.
49. Ricklin D., et al. Complement: a key system for immune surveillance and homeostasis. Nat. Immunol. 2010, 11:785-797.
50. Hajishengallis G. Complement and periodontitis. Biochem. Pharmacol. 2010, 80:1992-2001.
51. Potempa M., et al. Interpain A, a cysteine proteinase from Prevotella intermedia, inhibits complement by degrading complement factor C3. PLoS Pathog. 2009, 5:e1000316.
52. Popadiak K., et al. Biphasic effect of gingipains from Porphyromonas gingivalis on the human complement system. J. Immunol. 2007, 178:7242-7250.
53. Jusko M., et al. A metalloproteinase karilysin present in the majority of Tannerella forsythia isolates inhibits all pathways of the complement system. J. Immunol. 2012, 188:2338-2349.
54. Potempa M., et al. Binding of complement inhibitor C4b-binding protein contributes to serum resistance of Porphyromonas gingivalis. J. Immunol. 2008, 181:5537-5544.
55. McDowell J.V., et al. Analysis of a unique interaction between the complement regulatory protein factor H and the periodontal pathogen Treponema denticola. Infect. Immun. 2009, 77:1417-1425.
56. Krauss J.L., et al. Complementary Tolls in the periodontium: how periodontal bacteria modify complement and Toll-like receptor responses to prevail in the host. Periodontol. 2000 2010, 52:141-162.
57. Guo Y., et al. Dichotomy of gingipains action as virulence factors: from cleaving substrates with the precision of a surgeon's knife to a meat chopper-like brutal degradation of proteins. Periodontol. 2000 2010, 54:15-44.
58. Liang S., et al. The C5a receptor impairs IL-12-dependent clearance of Porphyromonas gingivalis and is required for induction of periodontal bone loss. J. Immunol. 2011, 186:869-877.
59. Sima C., Glogauer M. Neutrophil dysfunction and host susceptibility to periodontal inflammation: Current state of knowledge. Curr. Oral Health Rep. 2014, 1:95-103.
60. Nussbaum G., Shapira L. How has neutrophil research improved our understanding of periodontal pathogenesis?. J. Clin. Periodontol. 2011, 38:49-59.
61. Archer N.K., et al. Staphylococcus aureus biofilms: properties, regulation, and roles in human disease. Virulence 2011, 2:445-459.
62. Leid J.G., et al. Human leukocytes adhere to, penetrate, and respond to Staphylococcus aureus biofilms. Infect. Immun. 2002, 70:6339-6345.
63. Ryder M.I. Comparison of neutrophil functions in aggressive and chronic periodontitis. Periodontol. 2000 2010, 53:124-137.
64. Sol A., et al. Actin enables the antimicrobial action of LL-37 in the presence of microbial proteases. J. Biol. Chem. 2014, 289:22926-22941.
65. Gutner M., et al. Saliva enables the antimicrobial activity of LL-37 in the presence of proteases of Porphyromonas gingivalis. Infect. Immun. 2009, 77:5558-5563.
66. Maekawa T., et al. Porphyromonas gingivalis manipulates complement and TLR signaling to uncouple bacterial clearance from inflammation and promote dysbiosis. Cell Host Microbe 2014, 15:768-778.
67. Abe T., et al. Local complement-targeted intervention in periodontitis: proof-of-concept using a C5a receptor (CD88) antagonist. J. Immunol. 2012, 189:5442-5448.
68. Cutler C.W., et al. Inhibition of C3 and IgG proteolysis enhances phagocytosis of Porphyromonas gingivalis. J. Immunol. 1993, 151:7016-7029.
69. Sundqvist G., et al. Degradation of human immunoglobulins G and M and complement factors C3 and C5 by black-pigmented Bacteroides. J. Med. Microbiol. 1985, 19:85-94.
70. Grenier D., et al. Further studies on the degradation of immunoglobulins by black-pigmented Bacteroides. Oral Microbiol. Immunol. 1989, 4:12-18.
71. Vincents B., et al. Cleavage of IgG1 and IgG3 by gingipain K from Porphyromonas gingivalis may compromise host defense in progressive periodontitis. FASEB J. 2011, 25:3741-3750.
72. Delima A.J., Van Dyke T.E. Origin and function of the cellular components in gingival crevice fluid. Periodontol. 2000 2003, 31:55-76.
73. Nathan C. Role of iNOS in human host defense. Science 2006, 312:1874-1875. author reply 1874-1875.
74. Wang M., et al. Microbial hijacking of complement-toll-like receptor crosstalk. Sci. Signal. 2010, 3:ra11.
75. Coats S.R., et al. Human Toll-like receptor 4 responses to P. gingivalis are regulated by lipid A 1- and 4'-phosphatase activities. Cell Microbiol. 2009, 11:1587-1599.
76. Zenobia C., et al. Porphyromonas gingivalis lipid A phosphatase activity is critical for colonization and increasing the commensal load in the rabbit ligature model. Infect. Immun. 2014, 82:650-659.
77. Slocum C., et al. Distinct lipid A moieties contribute to pathogen-induced site-specific vascular inflammation. PLoS Pathog. 2014, 10:e1004215.
78. Lamkanfi M., Dixit V.M. Mechanisms and functions of inflammasomes. Cell 2014, 157:1013-1022.
79. Shi J., et al. Inflammatory caspases are innate immune receptors for intracellular LPS. Nature 2014, 514:187-192.
80. Taxman D.J., et al. Porphyromonas gingivalis mediates inflammasome repression in polymicrobial cultures through a novel mechanism involving reduced endocytosis. J. Biol. Chem. 2012, 287:32791-32799.
81. Hasegawa Y., et al. Role of Porphyromonas gingivalis SerB in gingival epithelial cell cytoskeletal remodeling and cytokine production. Infect. Immun. 2008, 76:2420-2427.
82. Stecher B., et al. 'Blooming' in the gut: how dysbiosis might contribute to pathogen evolution. Nat. Rev. Microbiol. 2013, 11:277-284.
83. Garrett W.S., et al. Enterobacteriaceae act in concert with the gut microbiota to induce spontaneous and maternally transmitted colitis. Cell Host Microbe 2010, 8:292-300.
84. Bornigen D., et al. Functional profiling of the gut microbiome in disease-associated inflammation. Genome Med. 2013, 5:65.
85. Sears C.L., Pardoll D.M. Perspective: alpha-bugs, their microbial partners, and the link to colon cancer. J. Infect. Dis. 2011, 203:306-311.
86. Belkaid Y., Naik S. Compartmentalized and systemic control of tissue immunity by commensals. Nat. Immunol. 2013, 14:646-653.
87. Page R.C., et al. Immunization of Macaca fascicularis against experimental periodontitis using a vaccine containing cysteine proteases purified from Porphyromonas gingivalis. Oral Microbiol. Immunol. 2007, 22:162-168.
88. Hajishengallis G., et al. The keystone-pathogen hypothesis. Nat. Rev. Microbiol. 2012, 10:717-725.
89. Jorth P., et al. Metatranscriptomics of the human oral microbiome during health and disease. MBio 2014, 5:e01012-e01014.
90. Duran-Pinedo A.E., et al. The periodontal pathogen Porphyromonas gingivalis induces expression of transposases and cell death of Streptococcus mitis in a biofilm model. Infect. Immun. 2014, 82:3374-3382.